Health Condition 1: null- Patients with an abnormal prostate on a digital rectal examination and/or serum prostate specific antigen more than 4 ng/ml were included in the study.
Conditions
Interventions
Intervention1: Pelvic plexus block: 5 ml of 25 lignocaine injection was given on each side into the pelvic neurovascular plexus, situated lateral to the tip of the seminal vesicles under colour Dopple
Sponsors
Tarun Jindal
Eligibility
Inclusion criteria
Inclusion criteria: Patients with an abnormal prostate on a digital rectal examination and/or serum prostate specific antigen (PSA) of > 4 ng/ml were included in the study.
Exclusion criteria
Exclusion criteria: Those who have had a previous transrectal prostate biopsy, chronic prostatitis/pelvic pain, neurological conditions, bleeding diathesis, anticoagulation/antiplatelet therapy, active UTI, haemorrhoids/ anal fissure/ anal fistula, known allergy to lignocaine were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of pelvic plexus block as compared to the pei prostatic block and placebo on the pain during prostate biopsyTimepoint: The evaluation of pain using the visual analogue scale will be made at two pints: 1) During the biopsy 2) 30 minutes following the biopsy | — |
Secondary
| Measure | Time frame |
|---|---|
| The complications occuring due to the biopsy procedureTimepoint: The patients were observed for 2 hours after the procedure.The patients were reviewed again at the end of two weeks to assess the late complication rate. | — |
Countries
India
Contacts
Public Contacttarun jindal
Calcutta National Medical College
Outcome results
None listed